Deal Capsule

Deal Capsule

Transactions in Chemicals & Pharmaceuticals

Transactions in Chemicals & Pharmaceuticals

According to a global survey conducted by KPMG in collaboration with Mergers & Acquisitions Magazine pharmaceuticals/biotechnology are expected to be among the top three industries most active in M&A in 2017.

KPMG’s Deal Thermometer indicates that the environment for M&A activity will remain moderately strong in pharmaceuticals.

 

Connect with us

KPMG's new digital platform

KPMG International has created a state of the art digital platform that enhances your experience, optimized to discover new and related content.

Deal Capsule - Transactions in Pharmaceuticals April 2017

Pharmaceutical M&A turned its focus on biotech targets to seize late-stage assets. Generics and animal health were further key areas of interest.

 
Read more

Deal Capsule - Transactions in Chemicals April 2017

In chemicals, several mega deals are close to completion. Activity was spread across the value chain with a focus on agrochemicals. PE activity was subdued due to high valuations.

 
Read more